Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCL Younger Trial: R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
NCT00209222Phase 3Unknown
- Sponsor
- European Mantle Cell Lymphoma Network
- Start
- Jul 2004
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cytarabine in mantle cell lymphoma (MCL), sponsored by European Mantle Cell Lymphoma Network. Status: unknown.
02
Drugs
cytarabine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00209222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209222.